|
1
|
Horimoto T and Kawaoka Y: Influenza:
Lessons from past pandemics, warnings from current incidents. Nat
Rev Microbiol. 3:591–600. 2005.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Hause BM, Collin EA, Liu R, Huang B, Sheng
Z, Lu W, Wang D, Nelson EA and Li F: Characterization of a novel
influenza virus in cattle and Swine: Proposal for a new genus in
the Orthomyxoviridae family. MBio. 5:e00031–e14.
2014.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Lee VJ, Ho ZJM, Goh EH, Campbell H, Cohen
C, Cozza V, Fitzner J, Jara J, Krishnan A and Bresee J: WHO Working
Group on Influenza Burden of Disease. Advances in measuring
influenza burden of disease. Influenza Other Respir Viruses.
12:3–9. 2018.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Mungall BA, Xu X and Klimov A:
Surveillance of influenza isolates for susceptibility to
neuraminidase inhibitors during the 2000-2002 influenza seasons.
Virus Res. 103:195–197. 2004.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Nguyen JT, Smee DF, Barnard DL, Julander
JG, Gross M, de Jong MD and Went GT: Efficacy of combined therapy
with amantadine, oseltamivir, and ribavirin in vivo against
susceptible and amantadine-resistant influenza A viruses. PLoS One.
7(e31006)2012.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Pazgier M, Li X, Lu W and Lubkowski J:
Human defensins: Synthe- sis and structural properties. Curr Pharm
Des. 13:3096–3118. 2007.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Shah R and Chang TL: Defensins in viral
infection. In: Small Wonders: Peptides for Disease Control.
Rajasekaran K, Cary JW, Jaynes JM, Montesinos E (eds). Vol 1095.
ACS Symposium Series, pp137-171, 2012. https://doi.org/10.1021/bk-2012-1095.ch007.
|
|
8
|
Jiang Y, Yang D, Li W, Wang B, Jiang Z and
Li M: Antiviral activity of recombinant mouse β-defensin 3 against
influenza A virus in vitro and in vivo. Antivir Chem Chemother.
22:255–262. 2012.PubMed/NCBI View
Article : Google Scholar
|
|
9
|
Jiang Y, Wang Y, Kuang Y, Wang B, Li W,
Gong T, Jiang Z, Yang D and Li M: Expression of mouse β-defensin-3
in MDCK cells and its anti-influenza-virus activity. Arch Virol.
154:639–647. 2009.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Yang SH, Sharrocks AD and Whitmarsh AJ:
MAP kinase signalling cascades and transcriptional regulation.
Gene. 513:1–13. 2013.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Haarmann H, Steiner T, Schreiber F,
Heinrich A, Zweigner J, N’Guessan PD and Slevogt H: The role and
regulation of Moraxella catarrhalis-induced human
beta-defensin 3 expression in human pulmonary epithelial cells.
Biochem Biophys Res Commun. 467:46–52. 2015.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Chacko SM, Thambi PT, Kuttan R and
Nishigaki I: Beneficial effects of green tea: A literature review.
Chin Med. 5(13)2010.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Kim M, Kim SY, Lee HW, Shin JS, Kim P,
Jung YS, Jeong HS, Hyun JK and Lee CK: Inhibition of influenza
virus internalization by (-)-epigallocatechin-3-gallate. Antiviral
Res. 100:460–472. 2013.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Gan Y, Cui X, Ma T, Liu Y, Li A and Huang
M: Paeoniflorin upregulates β-defensin-2 expression in human
bronchial epithelial cell through the p38 MAPK, ERK, and NF-κB
signaling pathways. Inflammation. 37:1468–1475. 2014.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Fusco A, Savio V, Cammarota M, Alfano A,
Schiraldi C and Donnarumma G: Schiraldi C and Donnarumma G: Beta-
defensin-2 and beta-defensin-3 reduce intestinal damage caused by
Salmonella typhimurium modulating the expression of
cytokines and enhancing the probiotic activity of Enterococcus
faecium. J Immunol Res. 2017(6976935)2017.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Valore EV, Park CH, Quayle AJ, Wiles KR,
McCray PB Jr and Ganz T: Human beta-defensin-1: An antimicrobial
peptide of urogenital tissues. J Clin Invest. 101:1633–1642.
1998.PubMed/NCBI View
Article : Google Scholar
|
|
17
|
Reichel M, Heisig A, Heisig P and Kampf G:
Skin bacteria after chlorhexidine exposure-is there a difference in
response to human beta-Defensin-3? Eur J Clin Microbiol Infect Dis.
29:623–632. 2010.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Bezniakow N, Gos M and Obersztyn E: The
RASopathies as an example of RAS/MAPK pathway disturbances -
clinical presentation and molecular pathogenesis of selected
syndromes. Dev Period Med. 18:285–296. 2014.PubMed/NCBI
|
|
19
|
Kono M, Tatsumi K, Imai AM, Saito K,
Kuriyama T and Shirasawa H: Kuriyama T and Shirasawa H: Inhibition
of human coronavirus 229E infection in human epithelial lung cells
(L132) by chloroquine: Involvement of p38 MAPK and ERK. Antiviral
Res. 77:150–152. 2008.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Sui X, Kong N, Ye L, Han W, Zhou J, Zhang
Q, He C and Pan H: p38 and JNK MAPK pathways control the balance of
apoptosis and autophagy in response to chemotherapeutic agents.
Cancer Lett. 344:174–179. 2014.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Cerezo-Guisado MI, Zur R, Lorenzo MJ,
Risco A, Martín-Serrano MA, Alvarez-Barrientos A, Cuenda A and
Centeno F: Implication of Akt, ERK1/2 and alternative p38MAPK
signalling pathways in human colon cancer cell apoptosis induced by
green tea EGCG. Food Chem Toxicol. 84:125–132. 2015.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Boughan PK, Argent RH, Body-Malapel M,
Park JH, Ewings KE, Bowie AG, Ong SJ, Cook SJ, Sorensen OE, Manzo
BA, et al: Nucleotide-binding oligomerization domain-1 and
epidermal growth factor receptor: Critical regulators of
beta-defensins during Helicobacter pylori infection. J Biol
Chem. 281:11637–11648. 2006.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Liu J, Du X, Chen J, Hu L and Chen L: The
induction expression of human β-defensins in gingival epithelial
cells and fibroblasts. Arch Oral Biol. 58:1415–1421.
2013.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Paoletti I, Buommino E, Fusco A, Baudouin
C, Msika P, Tufano MA, Baroni A and Donnarumma G: Patented natural
avocado sugar modulates the HBD-2 and HBD-3 expression in human
keratinocytes through toll-like receptor-2 and ERK/MAPK activation.
Arch Dermatol Res. 304:619–625. 2012.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Colpitts CC and Schang LM: A small
molecule inhibits virion attachment to heparan sulfate- or sialic
acid-containing glycans. J Virol. 88:7806–7817. 2014.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Kesic MJ, Simmons SO, Bauer R and Jaspers
I: Nrf2 expression modifies influenza A entry and replication in
nasal epithelial cells. Free Radic Biol Med. 51:444–453.
2011.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Xu MJ, Liu BJ, Wang CL, Wang GH, Tian Y,
Wang SH, Li J, Li PY, Zhang RH, Wei D, et al:
Epigallocatechin-3-gallate inhibits TLR4 signaling through the
67-kDa laminin receptor and effectively alleviates acute lung
injury induced by H9N2 swine influenza virus. Int Immunopharmacol.
52:24–33. 2017.PubMed/NCBI View Article : Google Scholar
|
